Hemostasis and thrombosis in critically ill children

Area of Science:

• Pediatric Critical Care Medicine
• Hematology
• Pediatric Intensive Care Unit (PICU) hemostasis

Background:

• Pediatric intensive care unit (PICU) patients frequently exhibit hemostatic abnormalities.
• Bleeding complications are significant in pediatric surgery, trauma, and cardiac operations.
• Thromboembolic events in children are increasingly recognized due to diagnostic and therapeutic advancements.

Purpose of the Study:

• To review the pathophysiology of hemostasis disorders in critically ill pediatric patients.
• To discuss the risk factors associated with bleeding and thromboembolic events in the PICU.
• To outline current therapeutic options for managing hemostasis abnormalities in this population.

Main Methods:

• Literature review of studies on pediatric intensive care unit (PICU) hemostasis.
• Analysis of pathophysiologic conditions affecting coagulation in critically ill children.
• Synthesis of information on risk factors and treatment strategies.

Main Results:

• Young infants are particularly vulnerable to bleeding and thrombosis due to immature hemostatic systems.
• Conditions like infection, hypotension, and acidosis can precipitate disseminated intravascular coagulation (DIC).
• Disseminated intravascular coagulation (DIC) in critically ill children can manifest as either bleeding or thrombosis.

Conclusions:

• Effective management of hemostasis in critically ill pediatric patients requires a comprehensive understanding of underlying conditions.
• Early recognition and intervention are crucial for mitigating bleeding and thrombotic complications.
• This review provides insights into the challenges and therapeutic approaches for pediatric intensive care unit (PICU) hemostasis.